Completion of the human papillomavirus (HPV) vaccine series among males with private insurance between 2006 and 2009

Jacqueline M. Hirth, Alai Tan, Gregg S. Wilkinson, Abbey B. Berenson

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

Little is known about initiation and completion among males who received the HPV vaccine on an off-label basis before 2009. This study utilized administrative claims data from a private insurance company to examine completion of the 3 dose HPV series among 514 males who initiated the vaccine between 2006 and May of 2009. Frequencies of HPV vaccination were examined and multivariate logistic regression estimated the odds of completing the entire series within 365 days of initiation. We found that only 21% of male initiators completed all 3 vaccine doses within 12 months and completion decreased over time. Series completion did not vary significantly by provider type. These findings suggest that difficulties may be encountered in fully vaccinating enough males to achieve adequate herd immunity in the future.

Original languageEnglish (US)
Pages (from-to)1138-1140
Number of pages3
JournalVaccine
Volume31
Issue number8
DOIs
StatePublished - Feb 6 2013

Keywords

  • HPV vaccines
  • Human papillomavirus
  • Human papillomavirus vaccine L1
  • Male HPV vaccine series completion
  • Papillomavirus vaccines

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)
  • Molecular Medicine

Fingerprint Dive into the research topics of 'Completion of the human papillomavirus (HPV) vaccine series among males with private insurance between 2006 and 2009'. Together they form a unique fingerprint.

  • Cite this